Quick Answer
ZEVRA THERAPEUTICS, INC. reported Net Income Loss of $83.23 million for the year ending 2025.
- ZEVRA THERAPEUTICS, INC. showed an increase of +178.9% in Net Income Loss from 2024 to 2025.
- This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), ZEVRA THERAPEUTICS, INC.'s Net Income Loss has grown by 1,692.6%.
- Historical annual values: Fiscal year 2025: $83.23 million | Fiscal year 2024: -$105.51 million | Fiscal year 2023: -$46.05 million | Fiscal year 2022: -$26.77 million | Fiscal year 2021: -$8.56 million | Fiscal year 2020: -$12.76 million | Fiscal year 2019: -$24.52 million | Fiscal year 2018: -$56.47 million | Fiscal year 2017: -$43.39 million | Fiscal year 2016: -$16.52 million | Fiscal year 2015: -$54.66 million | Fiscal year 2014: -$24.46 million | Fiscal year 2013: -$5.23 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: